Jump to main content
Jump to site search

Issue 47, 2016
Previous Article Next Article

5-Aryl-2-(naphtha-1-yl)sulfonamido-thiazol-4(5H)-ones as clathrin inhibitors

Author affiliations


The development of a (Z)-5-((6,8-dichloro-4-oxo-4H-chromen-3-yl)methylene)-2-thioxothiazolidin-4-one (2), rhodanine-based lead that led to the Pitstop® 2 family of clathrin inhibitors is described herein. Head group substitution and bioisosteric replacement of the rhodanine core with a 2-aminothiazol-4(5H)-one scaffold eliminated off target dynamin activity. A series of N-substituents gave first phenylglycine (20, IC50 ∼ 20 μM) then phenyl (25, IC50 ∼ 7.1 μM) and 1-napthyl sulfonamide (26, Pitstop® 2 compound, IC50 ∼ 1.9 μM) analogues with good activity, validating this approach. A final library exploring the head group resulted in three analogues displaying either slight improvements or comparable activity (33, 38, and 29 with IC50 ∼ 1.4, 1.6 and 1.8 μM respectively) and nine others with IC50 < 10 μM. These results were rationalized using in silico docking studies. Docking studies predicted enhanced Pitstop® 2 family binding, not a loss of binding, within the Pistop® groove of the reported clathrin mutant invalidating recent assumptions of poor selectivity for this family of clathrin inhibitors.

Graphical abstract: 5-Aryl-2-(naphtha-1-yl)sulfonamido-thiazol-4(5H)-ones as clathrin inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 21 Oct 2016, accepted on 04 Nov 2016 and first published on 04 Nov 2016

Article type: Paper
DOI: 10.1039/C6OB02308H
Org. Biomol. Chem., 2016,14, 11266-11278

  •   Request permissions

    5-Aryl-2-(naphtha-1-yl)sulfonamido-thiazol-4(5H)-ones as clathrin inhibitors

    M. J. Robertson, A. Horatscheck, S. Sauer, L. von Kleist, J. R. Baker, W. Stahlschmidt, M. Nazaré, A. Whiting, N. Chau, P. J. Robinson, V. Haucke and A. McCluskey, Org. Biomol. Chem., 2016, 14, 11266
    DOI: 10.1039/C6OB02308H

Search articles by author